Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;86:125-130

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayes-Genis, A.
Right arrow Articles by Schwartz, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayes-Genis, A.
Right arrow Articles by Schwartz, R. S.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Cell biology/structural biology
(Circulation Research. 2000;86:125.)
© 2000 American Heart Association, Inc.


MiniReview

The Insulin-Like Growth Factor Axis

A Review of Atherosclerosis and Restenosis

Antoni Bayes-Genis, Cheryl A. Conover, Robert S. Schwartz

From the Division of Cardiovascular Diseases (A.B.-G., R.S.S.) and Endocrine Research Unit (C.A.C.), Mayo Clinic and Foundation, Rochester, Minn.

Correspondence to Robert S. Schwartz, MD, Department of Cardiovascular Diseases, Mayo Clinic, 200 First St, SW, Rochester, MN 55905. E-mail schwartzr{at}mayo.edu

Abstract—Insulin-like growth factors I and II (IGF-I and -II) and their regulatory proteins are secreted by cells of the cardiovascular system. They are growth promoters for arterial cells and mediators of cardiovascular disease. IGFs are bound to IGF binding proteins (IGFBPs), which modulate IGF ligand-receptor interaction and consequently to IGF action. IGFBPs are in turn posttranslationally modulated by specific proteases. This dynamic balance (IGFs, IGFBPs, and IGFBP proteases) constitutes the IGF axis and ultimately determines the extent of IGF-dependent cellular effects. Dysregulated actions of this axis influence coronary atherosclerosis through effects on vascular smooth muscle cell growth, migration, and extracellular matrix synthesis in the atherosclerotic plaque. IGF-I promotes macrophage chemotaxis, excess LDL cholesterol uptake, and release of proinflammatory cytokines. Endothelial cells also receive the effects of IGFs stimulating their migration and organization forming capillary networks. Neointimal hyperplasia of restenosis after coronary artery injury is also modulated by the IGF axis. IGFs stimulate vascular smooth muscle cell proliferation and migration to form the neointima and upregulate tropoelastin synthesis after disruption of the elastic layer. Understanding IGF axis regulation establishes a scientific basis for strategies directed to limit or reverse plaque growth and vulnerability in atherosclerosis and in the neointimal hyperplasia of restenosis.


Key Words: insulin-like growth factor • atherosclerosis • restenosis




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. Meng, D.-D. Lv, and J. Fang
Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells
Cardiovasc Res, July 7, 2008; (2008) cvn173v2.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Mikkelsen, C. Gyrup, P. Kristensen, M. T. Overgaard, C. B. Poulsen, L. S. Laursen, and C. Oxvig
Inhibition of the Proteolytic Activity of Pregnancy-associated Plasma Protein-A by Targeting Substrate Exosite Binding
J. Biol. Chem., June 13, 2008; 283(24): 16772 - 16780.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Han, J. Deng, L. Guo, C. Yan, M. Liang, J. Kang, H. Liu, A. M. Graham, and S. Li
CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery
Cardiovasc Res, June 1, 2008; 78(3): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Mayr, A. Zampetaki, A. Sidibe, U. Mayr, X. Yin, A. I. De Souza, Y.-L. Chung, B. Madhu, P. H. Quax, Y. Hu, et al.
Proteomic and Metabolomic Analysis of Smooth Muscle Cells Derived From the Arterial Media and Adventitial Progenitors of Apolipoprotein E-Deficient Mice
Circ. Res., May 9, 2008; 102(9): 1046 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Ning, A. G. P. Schuller, C. A. Conover, and J. E. Pintar
Insulin-Like Growth Factor (IGF) Binding Protein-4 Is Both a Positive and Negative Regulator of IGF Activity in Vivo
Mol. Endocrinol., May 1, 2008; 22(5): 1213 - 1225.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Martin, D. Gunnell, E. Whitley, A. Nicolaides, M. Griffin, N. Georgiou, G. Davey Smith, S. Ebrahim, and J. M. P. Holly
Associations of Insulin-Like Growth Factor (IGF)-I, IGF-II, IGF Binding Protein (IGFBP)-2 and IGFBP-3 with Ultrasound Measures of Atherosclerosis and Plaque Stability in an Older Adult Population
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1331 - 1338.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Jorn Schneider, J. Klotsche, B. Saller, S. Bohler, C. Sievers, D. Pittrow, G. Ruf, W. Marz, W. Erwa, A. M Zeiher, et al.
Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients
Eur. J. Endocrinol., February 1, 2008; 158(2): 153 - 161.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Pellitero, J. L. Reverter, E. Pizarro, M. C. Pastor, M. L. Granada, D. Tassies, J.-C. Reverter, I. Salinas, and A. Sanmarti
Pregnancy-Associated Plasma Protein-A Levels Are Related to Glycemic Control but Not to Lipid Profile or Hemostatic Parameters in Type 2 Diabetes
Diabetes Care, December 1, 2007; 30(12): 3083 - 3085.
[Full Text] [PDF]


Home page
JNMHome page
L. G. Spagnoli, E. Bonanno, G. Sangiorgi, and A. Mauriello
Role of Inflammation in Atherosclerosis
J. Nucl. Med., November 1, 2007; 48(11): 1800 - 1815.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Song, A. L. Mowbray, M. C. Sykes, and H. Jo
Emerging Role of IGF-1R in Stretch-Induced Neointimal Hyperplasia in Venous Grafts
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1679 - 1681.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-L. Niu, J. Li, Z. S. Hakim, M. Rojas, M. S. Runge, and N. R. Madamanchi
Leukocyte Antigen-related Deficiency Enhances Insulin-like Growth Factor-1 Signaling in Vascular Smooth Muscle Cells and Promotes Neointima Formation in Response to Vascular Injury
J. Biol. Chem., July 6, 2007; 282(27): 19808 - 19819.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. C. Harrington, R. D. Simari, and C. A. Conover
Genetic Deletion of Pregnancy-Associated Plasma Protein-A Is Associated With Resistance to Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice Challenged With a High-Fat Diet
Circ. Res., June 22, 2007; 100(12): 1696 - 1702.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Cheng, M.-J. Kim, G. Jia, and D. K. Agrawal
Involvement of chloride channels in IGF-I-induced proliferation of porcine arterial smooth muscle cells
Cardiovasc Res, January 1, 2007; 73(1): 198 - 207.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. T. Resch, R. D. Simari, and C. A. Conover
Targeted Disruption of the Pregnancy-Associated Plasma Protein-A Gene Is Associated with Diminished Smooth Muscle Cell Response to Insulin-like Growth Factor-I and Resistance to Neointimal Hyperplasia after Vascular Injury
Endocrinology, December 1, 2006; 147(12): 5634 - 5640.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. S. Johansson and H. J. Arnqvist
Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1124 - E1130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. M. Risinger Jr., T. S. Hunt, D. L. Updike, E. C. Bullen, and E. W. Howard
Matrix Metalloproteinase-2 Expression by Vascular Smooth Muscle Cells Is Mediated by Both Stimulatory and Inhibitory Signals in Response to Growth Factors
J. Biol. Chem., September 8, 2006; 281(36): 25915 - 25925.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J.-W. Chen, M. F Nielsen, A. Caumo, H. Vilstrup, J. S. Christiansen, and J. Frystyk
Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis.
Eur. J. Endocrinol., August 1, 2006; 155(2): 285 - 292.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Sangiorgi, A. Mauriello, E. Bonanno, C. Oxvig, C. A. Conover, M. Christiansen, S. Trimarchi, V. Rampoldi, D. R. Holmes Jr, R. S. Schwartz, et al.
Pregnancy-Associated Plasma Protein-A Is Markedly Expressed by Monocyte-Macrophage Cells in Vulnerable and Ruptured Carotid Atherosclerotic Plaques: A Link Between Inflammation and Cerebrovascular Events
J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2201 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. M. Biasucci and V. Rizzello
Pregnancy-associated plasma protein-a: do specific markers of vascular or plaque activation exist, and do we really need them?
Clin. Chem., June 1, 2006; 52(6): 913 - 914.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Mueller, B. Dieplinger, W. Poelz, and M. Haltmayer
Increased Pregnancy-Associated Plasma Protein-A as a Marker for Peripheral Atherosclerosis: Results from the Linz Peripheral Arterial Disease Study
Clin. Chem., June 1, 2006; 52(6): 1096 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. J. Schneider, B. Saller, J. Klotsche, W. Marz, W. Erwa, H.-U. Wittchen, and G. K. Stalla
Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects.
Eur. J. Endocrinol., May 1, 2006; 154(5): 699 - 706.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. D. Oldroyd, Y. Miyamoto, A. Moir, T. S. Johnson, A. M. El Nahas, and J. L. Haylor
An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F695 - F702.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. X.-F. Deng, A. Tsalenko, A. Vailaya, A. Ben-Dor, R. Kundu, I. Estay, R. Tabibiazar, R. Kincaid, Z. Yakhini, L. Bruhn, et al.
Differences in Vascular Bed Disease Susceptibility Reflect Differences in Gene Expression Response to Atherogenic Stimuli
Circ. Res., February 3, 2006; 98(2): 200 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M J E van Rijn, A J C Slooter, M J Bos, C F B S Catarino, P J Koudstaal, A Hofman, M M B Breteler, and C M van Duijn
Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 24 - 27.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. A. Conover, L. K. Bale, S. C. Harrington, Z. T. Resch, M. T. Overgaard, and C. Oxvig
Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C183 - C188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. K. Berfield, A. Chait, J. F. Oram, R. A. Zager, A. C. Johnson, and C. K. Abrass
IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F138 - F147.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. P. Johnsen, H. H. Hundborg, H. T. Sorensen, H. Orskov, A. Tjonneland, K. Overvad, and J. O. L. Jorgensen
Insulin-Like Growth Factor (IGF) I, -II, and IGF Binding Protein-3 and Risk of Ischemic Stroke
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5937 - 5941.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Cosin-Sales, J. C. Kaski, M. Christiansen, P. Kaminski, C. Oxvig, M. T. Overgaard, D. Cole, and D. W. Holt
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris
Eur. Heart J., October 2, 2005; 26(20): 2093 - 2098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Md. R. Abid, K. Yano, S. Guo, V. I. Patel, G. Shrikhande, K. C. Spokes, C. Ferran, and W. C. Aird
Forkhead Transcription Factors Inhibit Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia
J. Biol. Chem., August 19, 2005; 280(33): 29864 - 29873.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Garcia-Touchard, T. D. Henry, G. Sangiorgi, L. G. Spagnoli, A. Mauriello, C. Conover, and R. S. Schwartz
Extracellular Proteases in Atherosclerosis and Restenosis
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1119 - 1127.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Colao, C. Di Somma, F. Rota, S. Di Maio, M. Salerno, A. Klain, S. Spiezia, and G. Lombardi
Common Carotid Intima-Media Thickness in Growth Hormone (GH)-Deficient Adolescents: A Prospective Study after GH Withdrawal and Restarting GH Replacement
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2659 - 2665.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. L. Hunton, W. G. Barnes, J. Kim, X.-R. Ren, J. D. Violin, E. Reiter, G. Milligan, D. D. Patel, and R. J. Lefkowitz
{beta}-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
Mol. Pharmacol., April 1, 2005; 67(4): 1229 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Radcliff, T.-B. Tang, J. Lim, Z. Zhang, M. Abedin, L. L. Demer, and Y. Tintut
Insulin-Like Growth Factor-I Regulates Proliferation and Osteoblastic Differentiation of Calcifying Vascular Cells via Extracellular Signal-Regulated Protein Kinase And Phosphatidylinositol 3-Kinase Pathways
Circ. Res., March 4, 2005; 96(4): 398 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. F. Liew, S. D. Wise, K. P. Yeo, and K. O. Lee
Insulin-Like Growth Factor Binding Protein-1 Is Independently Affected by Ethnicity, Insulin Sensitivity, and Leptin in Healthy, Glucose-Tolerant Young Men
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1483 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S.-i. Kawachi, N. Takeda, A. Sasaki, Y. Kokubo, K. Takami, H. Sarui, M. Hayashi, N. Yamakita, and K. Yasuda
Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Are Associated With Early Carotid Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 617 - 621.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. T. Wu and L. L. Wu
Association of Soluble Markers with Various Stages and Major Events of Atherosclerosis
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 240 - 250.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Q.-P. Qin, S. Kokkala, J. Lund, N. Tamm, L.-M. Voipio-Pulkki, and K. Pettersson
Molecular Distinction of Circulating Pregnancy-Associated Plasma Protein A in Myocardial Infarction and Pregnancy
Clin. Chem., January 1, 2005; 51(1): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Miceli, A. Tropea, F. Minici, M. Orlando, G. Lamanna, M. F. Gangale, B. Panetta, F. Tiberi, S. Vaccari, R. Canipari, et al.
Effects of Insulin-Like Growth Factor I and II on Prostaglandin Synthesis and Plasminogen Activator Activity in Human Umbilical Vein Endothelial Cells
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 372 - 378.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. A. Colangelo, K. Liu, and S. M. Gapstur
Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3, and Cardiovascular Disease Risk Factors in Young Black Men and White Men: The CARDIA Male Hormone Study
Am. J. Epidemiol., October 15, 2004; 160(8): 750 - 757.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Conti, C. Carrozza, E. Capoluongo, M. Volpe, F. Crea, C. Zuppi, and F. Andreotti
Insulin-Like Growth Factor-1 as a Vascular Protective Factor
Circulation, October 12, 2004; 110(15): 2260 - 2265.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Hayashi, K. Shibata, T. Morita, K. Iwasaki, M. Watanabe, and K. Sobue
Insulin Receptor Substrate-1/SHP-2 Interaction, a Phenotype-dependent Switching Machinery of Insulin-like Growth Factor-I Signaling in Vascular Smooth Muscle Cells
J. Biol. Chem., September 24, 2004; 279(39): 40807 - 40818.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Conti, F. Andreotti, C. Zuppi, J. Lund, T. Ilva, P. Porela, Q.-P. Qin, K. Pettersson, L.-M. Voipio-Pulkki, and K. Pulkki
Pregnancy-Associated Plasma Protein A as Predictor of Outcome in Patients With Suspected Acute Coronary Syndromes * Response
Circulation, May 11, 2004; 109(18): e211 - e212.
[Full Text] [PDF]


Home page
CirculationHome page
J. Cosin-Sales, M. Christiansen, P. Kaminski, C. Oxvig, M. T. Overgaard, D. Cole, D. W. Holt, and J. C. Kaski
Pregnancy-Associated Plasma Protein A and Its Endogenous Inhibitor, the Proform of Eosinophil Major Basic Protein (proMBP), Are Related to Complex Stenosis Morphology in Patients With Stable Angina Pectoris
Circulation, April 13, 2004; 109(14): 1724 - 1728.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Q. Xu, S. Li, Y. Zhao, T. J. Maures, P. Yin, and C. Duan
Evidence That IGF Binding Protein-5 Functions as a Ligand-Independent Transcriptional Regulator in Vascular Smooth Muscle Cells
Circ. Res., March 19, 2004; 94(5): e46 - e54.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Singhal, T. J. Cole, M. Fewtrell, J. Deanfield, and A. Lucas
Is Slower Early Growth Beneficial for Long-Term Cardiovascular Health?
Circulation, March 9, 2004; 109(9): 1108 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Delafontaine, Y.-H. Song, and Y. Li
Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 435 - 444.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
E. F LaBelle and T. N Tulenko
LDL, IGF-1, and VSMC apoptosis: linking atherogenesis to plaque rupture in vulnerable lesions
Cardiovasc Res, February 1, 2004; 61(2): 204 - 205.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
B Gonzalez-Timon, M Gonzalez-Munoz, C Zaragoza, S Lamas, and E.M Melian
Native and oxidized low density lipoproteins oppositely modulate the effects of insulin-like growth factor I on VSMC
Cardiovasc Res, February 1, 2004; 61(2): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. A. Laughlin, E. Barrett-Connor, M. H. Criqui, and D. Kritz-Silverstein
The Prospective Association of Serum Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-1 Levels with All Cause and Cardiovascular Disease Mortality in Older Adults: The Rancho Bernardo Study
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 114 - 120.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Girnita, L. Girnita, F. d. Prete, A. Bartolazzi, O. Larsson, and M. Axelson
Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth
Cancer Res., January 1, 2004; 64(1): 236 - 242.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. Ruiz-Torres, R. Lozano, J. Melon, and R. Carraro
Age-Dependent Decline of In Vitro Migration (Basal and Stimulated by IGF-1 or Insulin) of Human Vascular Smooth Muscle Cells
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): B1074 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hsieh, R. E. Gordon, D. R. Clemmons, W. H. Busby Jr., and C. Duan
Regulation of Vascular Smooth Muscle Cell Responses to Insulin-like Growth Factor (IGF)-I by Local IGF-binding Proteins
J. Biol. Chem., October 31, 2003; 278(44): 42886 - 42892.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Sasaoka, K. Kikuchi, T. Wada, A. Sato, H. Hori, S. Murakami, K. Fukui, H. Ishihara, R. Aota, I. Kimura, et al.
Dual Role of Src Homology Domain 2-Containing Inositol Phosphatase 2 in the Regulation of Platelet-Derived Growth Factor and Insulin-Like Growth Factor I Signaling in Rat Vascular Smooth Muscle Cells
Endocrinology, September 1, 2003; 144(9): 4204 - 4214.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
A. La Batide-Alanore, D.-A. Tregouet, C. Sass, G. Siest, S. Visvikis, and L. Tiret
Family study of the relationship between height and cardiovascular risk factors in the STANISLAS cohort
Int. J. Epidemiol., August 1, 2003; 32(4): 607 - 614.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A.F.C. Schut, J.A.M.J.L. Janssen, J. Deinum, J.M. Vergeer, A. Hofman, S.W.J. Lamberts, B.A. Oostra, H.A.P. Pols, J.C.M. Witteman, and C.M. van Duijn
Polymorphism in the Promoter Region of the Insulin-like Growth Factor I Gene Is Related to Carotid Intima-Media Thickness and Aortic Pulse Wave Velocity in Subjects With Hypertension
Stroke, July 1, 2003; 34(7): 1623 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. B. Twickler, M. J. M. Cramer, G. M. Dallinga-Thie, M. J. Chapman, D. W. Erkelens, and H. P. F. Koppeschaar
Adult-Onset Growth Hormone Deficiency: Relation of Postprandial Dyslipidemia to Premature Atherosclerosis
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2479 - 2488.
[Full Text] [PDF]